General | 16 March 2024
Anupam Rasayan incorporates subsidiary in USA
Anupam Rasayan will make a capital investment of US$ 10,000 in Anupam USA, LLC.
Anupam Rasayan will make a capital investment of US$ 10,000 in Anupam USA, LLC.
Croda’s extensive library of natural compounds and manufacturing capabilities will help Moa develop breakthrough solutions with even greater speed and accuracy
The new complex will have an annual production capacity of 1 million tonnes of advanced phosphate fertilizers
Final decision subject to consultation with Stade Works Council and in accordance with German Law
The certification grants legal authorization for flying drones within the weight range of 25 kg to 150 kg
New campus to offer foundation program to prepare students for the academy’s core diploma program
Net income increases to € 443 million due to portfolio measures
New Sunbites packaging launched by PepsiCo for the well-known snack brand in UK and Ireland
Shakti Pumps India receives Rs. 73 order from HAREDA
Milliken applies its materials science expertise to develop innovative solutions
Aims to meet grower and industry needs for innovative biological crop protection products
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Ethane LLCs are limited liability companies incorporated on December 4, 2023 in the Republic of the Marshall Island
This acquisition is a significant step towards HIL's commitment to further accelerate its fast-growing Pipes & Fittings business
Solid financial performance due to the stronger first half, and robust capital structure opening a new chapter of Solvay
Sustainable rubber chemicals from LANXESS enable tire manufacturers to reduce their environmental footprint
SRF has incorporated a wholly owned subsidiary, SRF Middle East with an authorized capital of AED 365,000
Net income amounts to €327 million
The company will highlight its developments in plastics circularity
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
